Clinical Trial: A Study to Evaluate 20vPnC in Healthy Chinese Infants

U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07754539) titled 'A Study to Evaluate 20vPnC in Healthy Chinese Infants' on July 24.

Brief Summary: The purpose of this study is to evaluate a study vaccine called 20-valent pneumococcal conjugate vaccine (20vPnC). The study will assess whether the study vaccine is safe to use in healthy infants. It will also evaluate if the study vaccine can help the body make antibodies (known as immune response). These antibodies help protect against 20 types of pneumococcal bacteria. The study will compare 20vPnC with 13vPnC (control vaccine), which is approved for use in infants.

The study is seeking participants who:

* Are healthy infants

* Aged 42 to 98 day...